Creating a new NHS England: NHS Digital and NHS England have now merged. Health Education England will join us in April 2023. Learn more.
Patient Group Directions (PGDs) for COVID-19 vaccines
Patient Group Direction for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine
This Patient Group Direction (PGD) is for the administration of Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine to individuals 12 years of age and over as a booster dose.
Published 22 September 2022.
Patient group direction for Spikevax® Original/Omicron COVID-19 vaccine
This patient group direction (PGD) is for the administration of Spikevax® bivalent Original/Omicron COVID-19 vaccine to individuals 18 years and over as a booster dose.
Published 24 August 2022.
Patient Group Direction for Spikevax (formerly COVID-19 Vaccine Moderna)
This PGD is for the administration of Spikevax in accordance with the national COVID-19 vaccination programme.
Updated 31 March 2022.
Patient Group Direction for Comirnaty® (10micrograms/dose) concentrate for children 5-11 years
This PGD is for the administration of Comirnaty® 10 micrograms/dose COVID-19 mRNA vaccine to children aged 5 to 11 years in accordance with the national COVID-19 vaccination programme.
Updated 14 December 2022.
Patient Group Direction for Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine
This PGD is for the administration of Comirnaty® 30micrograms/dose COVID-19 mRNA vaccine to individuals from 12 years of age in accordance with the national COVID-19 vaccination programme.
Updated 31 March 2022.